| Metric | შპს SIAPHARM | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾3.9m₾4.5m | ₾1.02bn₾1.06bn |
| Revenue growth | -15.0% | -2.9% |
| Profitability | ||
| EBITDA | ₾379k₾12k | — |
| EBITDA margin | 9.8%0.3% | — |
| Net profit | ₾157k-₾63k | ₾306.5m₾512.9m |
| Net margin | 4.1%-1.4% | 29.9%48.6% |
| Balance sheet | ||
| Total assets | ₾1.7m₾1.8m | ₾21.77bn₾18.32bn |
| Total equity | ₾368k₾212k | ₾2.49bn₾2.08bn |
| ROE | 42.6%-30.0% | 12.3%24.7% |